EBS - Emergent BioSolutions Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript
Emergent BioSolutions, Inc. (EBS) Q1 2021 Earnings Conference Call April 29, 2021 5:00 PM ET Company Participants Robert Burrows - VP, IR Robert Kramer - CEO, President & Executive Director Richard Lindahl - EVP, CFO & Treasurer Adam Havey - EVP, Business Operations Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Dana Flanders - Guggenheim Securities Jessica Fye - JPMorgan Chase & Co. Keay Nakae - Chardan Capital Markets Lisa Springer - Singular Research Presentation Operator Thank you for standing by, and welcome to the Emergent BioSolutions First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to Bob Burrows. Please go ahead. Robert Burrows Thank you, Cindy. Good afternoon, everyone. My name is Bob Burrows, Investor Relations Officer for Emergent BioSolutions. Thank you for joining us today as we discuss the operational and financial results for the first quarter of
For further details see:
Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript